251 related articles for article (PubMed ID: 29691127)
1. Digenic Heterozigosity in SCN5A and CACNA1C Explains the Variable Expressivity of the Long QT Phenotype in a Spanish Family.
Nieto-Marín P; Jiménez-Jáimez J; Tinaquero D; Alfayate S; Utrilla RG; Rodríguez Vázquez Del Rey MDM; Perin F; Sarquella-Brugada G; Monserrat L; Brugada J; Tercedor L; Tamargo J; Delpón E; Caballero R
Rev Esp Cardiol (Engl Ed); 2019 Apr; 72(4):324-332. PubMed ID: 29691127
[TBL] [Abstract][Full Text] [Related]
2. Complex Brugada syndrome inheritance in a family harbouring compound SCN5A and CACNA1C mutations.
Béziau DM; Barc J; O'Hara T; Le Gloan L; Amarouch MY; Solnon A; Pavin D; Lecointe S; Bouillet P; Gourraud JB; Guicheney P; Denjoy I; Redon R; Mabo P; le Marec H; Loussouarn G; Kyndt F; Schott JJ; Probst V; Baró I
Basic Res Cardiol; 2014; 109(6):446. PubMed ID: 25341504
[TBL] [Abstract][Full Text] [Related]
3. Functional characterization of a novel SCN5A variant associated with long QT syndrome and sudden cardiac death.
Neubauer J; Wang Z; Rougier JS; Abriel H; Rieubland C; Bartholdi D; Haas C; Medeiros-Domingo A
Int J Legal Med; 2019 Nov; 133(6):1733-1742. PubMed ID: 31455979
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the CACNA1C-R518C Missense Mutation in the Pathobiology of Long-QT Syndrome Using Human Induced Pluripotent Stem Cell Cardiomyocytes Shows Action Potential Prolongation and L-Type Calcium Channel Perturbation.
Estes SI; Ye D; Zhou W; Dotzler SM; Tester DJ; Bos JM; Kim CSJ; Ackerman MJ
Circ Genom Precis Med; 2019 Aug; 12(8):e002534. PubMed ID: 31430211
[TBL] [Abstract][Full Text] [Related]
5. Impaired chromaffin cell excitability and exocytosis in autistic Timothy syndrome TS2-neo mouse rescued by L-type calcium channel blockers.
Calorio C; Gavello D; Guarina L; Salio C; Sassoè-Pognetto M; Riganti C; Bianchi FT; Hofer NT; Tuluc P; Obermair GJ; Defilippi P; Balzac F; Turco E; Bett GC; Rasmusson RL; Carbone E
J Physiol; 2019 Mar; 597(6):1705-1733. PubMed ID: 30629744
[TBL] [Abstract][Full Text] [Related]
6. Identification and Functional Characterization of a Novel CACNA1C-Mediated Cardiac Disorder Characterized by Prolonged QT Intervals With Hypertrophic Cardiomyopathy, Congenital Heart Defects, and Sudden Cardiac Death.
Boczek NJ; Ye D; Jin F; Tester DJ; Huseby A; Bos JM; Johnson AJ; Kanter R; Ackerman MJ
Circ Arrhythm Electrophysiol; 2015 Oct; 8(5):1122-32. PubMed ID: 26253506
[TBL] [Abstract][Full Text] [Related]
7. Novel long QT syndrome-associated missense mutation, L762F, in CACNA1C-encoded L-type calcium channel imparts a slower inactivation tau and increased sustained and window current.
Landstrom AP; Boczek NJ; Ye D; Miyake CY; De la Uz CM; Allen HD; Ackerman MJ; Kim JJ
Int J Cardiol; 2016 Oct; 220():290-8. PubMed ID: 27390944
[TBL] [Abstract][Full Text] [Related]
8. Further Insights in the Most Common SCN5A Mutation Causing Overlapping Phenotype of Long QT Syndrome, Brugada Syndrome, and Conduction Defect.
Veltmann C; Barajas-Martinez H; Wolpert C; Borggrefe M; Schimpf R; Pfeiffer R; Cáceres G; Burashnikov E; Antzelevitch C; Hu D
J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27381756
[TBL] [Abstract][Full Text] [Related]
9. Gain-of-function mutation in SCN5A causes ventricular arrhythmias and early onset atrial fibrillation.
Lieve KV; Verkerk AO; Podliesna S; van der Werf C; Tanck MW; Hofman N; van Bergen PF; Beekman L; Bezzina CR; Wilde AAM; Lodder EM
Int J Cardiol; 2017 Jun; 236():187-193. PubMed ID: 28262340
[TBL] [Abstract][Full Text] [Related]
10. Human iPS cell model of type 3 long QT syndrome recapitulates drug-based phenotype correction.
Malan D; Zhang M; Stallmeyer B; Müller J; Fleischmann BK; Schulze-Bahr E; Sasse P; Greber B
Basic Res Cardiol; 2016 Mar; 111(2):14. PubMed ID: 26803770
[TBL] [Abstract][Full Text] [Related]
11. A distinct molecular mechanism by which phenytoin rescues a novel long QT 3 variant.
Gando I; Campana C; Tan RB; Cecchin F; Sobie EA; Coetzee WA
J Mol Cell Cardiol; 2020 Jul; 144():1-11. PubMed ID: 32339567
[TBL] [Abstract][Full Text] [Related]
12. Digenic inheritance novel mutations in SCN5a and SNTA1 increase late I(Na) contributing to LQT syndrome.
Hu RM; Tan BH; Orland KM; Valdivia CR; Peterson A; Pu J; Makielski JC
Am J Physiol Heart Circ Physiol; 2013 Apr; 304(7):H994-H1001. PubMed ID: 23376825
[TBL] [Abstract][Full Text] [Related]
13. Variable Penetrance and Expressivity of a Rare Pore Loss-of-Function Mutation (p.L889V) of Nav1.5 Channels in Three Spanish Families.
Gallego-Delgado M; Cámara-Checa A; Rubio-Alarcón M; Heredero-Jung D; de la Fuente-Blanco L; Rapún J; Plata-Izquierdo B; Pérez-Martín S; Cebrián J; Moreno de Redrojo L; García-Berrocal B; Delpón E; Sánchez PL; Villacorta E; Caballero R
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731905
[TBL] [Abstract][Full Text] [Related]
14. A novel mutation in SCN5A, delQKP 1507-1509, causing long QT syndrome: role of Q1507 residue in sodium channel inactivation.
Keller DI; Acharfi S; Delacrétaz E; Benammar N; Rotter M; Pfammatter JP; Fressart V; Guicheney P; Chahine M
J Mol Cell Cardiol; 2003 Dec; 35(12):1513-21. PubMed ID: 14654377
[TBL] [Abstract][Full Text] [Related]
15. Gain-of-function mutations in the calcium channel CACNA1C (Cav1.2) cause non-syndromic long-QT but not Timothy syndrome.
Wemhöner K; Friedrich C; Stallmeyer B; Coffey AJ; Grace A; Zumhagen S; Seebohm G; Ortiz-Bonnin B; Rinné S; Sachse FB; Schulze-Bahr E; Decher N
J Mol Cell Cardiol; 2015 Mar; 80():186-95. PubMed ID: 25633834
[TBL] [Abstract][Full Text] [Related]
16. The molecular genetics of the long QT syndrome: genes causing fainting and sudden death.
Vincent GM
Annu Rev Med; 1998; 49():263-74. PubMed ID: 9509262
[TBL] [Abstract][Full Text] [Related]
17. Long QT syndrome type 8: novel CACNA1C mutations causing QT prolongation and variant phenotypes.
Fukuyama M; Wang Q; Kato K; Ohno S; Ding WG; Toyoda F; Itoh H; Kimura H; Makiyama T; Ito M; Matsuura H; Horie M
Europace; 2014 Dec; 16(12):1828-37. PubMed ID: 24728418
[TBL] [Abstract][Full Text] [Related]
18. Cardiac sodium channel mutation associated with epinephrine-induced QT prolongation and sinus node dysfunction.
Chen J; Makiyama T; Wuriyanghai Y; Ohno S; Sasaki K; Hayano M; Harita T; Nishiuchi S; Yuta Yamamoto ; Ueyama T; Shimizu A; Horie M; Kimura T
Heart Rhythm; 2016 Jan; 13(1):289-98. PubMed ID: 26282245
[TBL] [Abstract][Full Text] [Related]
19. A sodium channel pore mutation causing Brugada syndrome.
Pfahnl AE; Viswanathan PC; Weiss R; Shang LL; Sanyal S; Shusterman V; Kornblit C; London B; Dudley SC
Heart Rhythm; 2007 Jan; 4(1):46-53. PubMed ID: 17198989
[TBL] [Abstract][Full Text] [Related]
20. Patient-independent human induced pluripotent stem cell model: A new tool for rapid determination of genetic variant pathogenicity in long QT syndrome.
Chavali NV; Kryshtal DO; Parikh SS; Wang L; Glazer AM; Blackwell DJ; Kroncke BM; Shoemaker MB; Knollmann BC
Heart Rhythm; 2019 Nov; 16(11):1686-1695. PubMed ID: 31004778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
